Aziyo Biologics
-
Biologics
Aziyo Biologics Announces Voluntary Recall of Viable Bone Matrix Products
SILVER SPRING, Md., July 14, 2023 (GLOBE NEWSWIRE) — Aziyo Biologics, Inc. (Nasdaq: AZYO), a company that develops and commercializes…
Read More » -
Financial
Aziyo Biologics Reports Third Quarter 2021 Financial Results
SILVER SPRING, Md., Nov. 09, 2021 (GLOBE NEWSWIRE) — Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused…
Read More » -
Financial
Aziyo Biologics Reports Third Quarter 2020 Financial Results
SILVER SPRING, Md., Nov. 19, 2020 (GLOBE NEWSWIRE) — Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused…
Read More » -
Biologics
Surgalign Holdings and Aziyo Biologics Announce Expanded Distribution Agreement
Updated agreement expands availability of ViBone® Moldable, a next generation moldable cellular bone matrix product DEERFIELD, Ill. and SILVER SPRING,…
Read More » -
Biologics
Clinical Launch of SurGenTec® GraftGun® System Prefilled with ViBone® a Resounding Success
November 21, 2018 BOCA RATON, Fla.–(BUSINESS WIRE)–SurGenTec announced today the successful completion of the initial clinical launch of its new…
Read More » -
Biologics
RTI Surgical® and Aziyo® Biologics Announce Exclusive Agreement to Distribute ViBone® for Spine and Other Orthopedic Procedures
August 01, 2018 ALACHUA, Fla. & SILVER SPRING, Md.–(BUSINESS WIRE)–RTI Surgical, Inc. (Nasdaq: RTIX), a global surgical implant company, and…
Read More » -
Biologics
Aziyo Partners with SurGenTec for Minimally Invasive Bone Graft Delivery
July 13, 2018 SILVER SPRING, Md.–(BUSINESS WIRE)–Aziyo Biologics, Inc., a fully integrated regenerative medicine company, announced today it has entered…
Read More » -
Biologics
Aziyo Biologics Expands Bone Repair Franchise with Launch of OsteGro
March 22, 2018 SILVER SPRING, Md.–(BUSINESS WIRE)–Aziyo Biologics, Inc., a fully integrated regenerative medicine company, announced today the launch of…
Read More »